Jupiter Neurosciences, Inc. Stock Analysis & AI Score
Jupiter Neurosciences, Inc. (JUNS) has an ST Score of 29.9 (C-), driven by its Profitability (B) and held back by its Momentum (F). JUNS last traded at $2.88.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Jupiter Neurosciences, Inc. (JUNS) has an ST Score of 29.9 (C-), driven by its Profitability (B) and held back by its Momentum (F). JUNS last traded at $2.88.
- Strongest
- ProfitabilityB
- Weakest
- MomentumF
All factor grades
- ProfitabilityB
- Financial StrengthC-
- GrowthC-
- ValuationD
- MomentumF
- Piotroski3/9
Contact
JUNS stock: frequently asked questions
What is JUNS's ST Score?
Jupiter Neurosciences, Inc. (JUNS) has an ST Score of 29.9 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is JUNS a buy, hold, or sell?
Our ST Score grades it C- (29.9/100). The ST Score is a data-driven signal, not a recommendation.
What are JUNS's factor grades?
Valuation D, Profitability B, Financial Strength C-, Momentum F, Growth C-.
What is JUNS's valuation grade?
Jupiter Neurosciences, Inc. (JUNS) earns a valuation grade of D, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is JUNS's growth grade?
Jupiter Neurosciences, Inc. (JUNS) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is JUNS's profitability grade?
Jupiter Neurosciences, Inc. (JUNS) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is JUNS's financial strength grade?
Jupiter Neurosciences, Inc. (JUNS) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is JUNS's Piotroski score?
Jupiter Neurosciences, Inc. (JUNS) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.